JP2024534572A5 - - Google Patents
Info
- Publication number
- JP2024534572A5 JP2024534572A5 JP2024518371A JP2024518371A JP2024534572A5 JP 2024534572 A5 JP2024534572 A5 JP 2024534572A5 JP 2024518371 A JP2024518371 A JP 2024518371A JP 2024518371 A JP2024518371 A JP 2024518371A JP 2024534572 A5 JP2024534572 A5 JP 2024534572A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- solvate
- acceptable salt
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248334P | 2021-09-24 | 2021-09-24 | |
| US63/248,334 | 2021-09-24 | ||
| PCT/US2022/044562 WO2023049367A1 (en) | 2021-09-24 | 2022-09-23 | Pyridinylacetamide derivatives as sodium channel activators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534572A JP2024534572A (ja) | 2024-09-20 |
| JP2024534572A5 true JP2024534572A5 (https=) | 2025-10-01 |
Family
ID=83899862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518371A Pending JP2024534572A (ja) | 2021-09-24 | 2022-09-23 | ナトリウムチャンネル活性化剤としてのピリジニルアセトアミド誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20230203007A1 (https=) |
| EP (1) | EP4405351A1 (https=) |
| JP (1) | JP2024534572A (https=) |
| KR (1) | KR20240070604A (https=) |
| CN (1) | CN120265625A (https=) |
| AU (1) | AU2022351156A1 (https=) |
| CA (1) | CA3231743A1 (https=) |
| IL (1) | IL311057A (https=) |
| MX (1) | MX2024003645A (https=) |
| TW (1) | TW202328091A (https=) |
| WO (1) | WO2023049367A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12054486B2 (en) | 2021-09-24 | 2024-08-06 | Xenon Pharmaceuticals Inc. | Pyridine derivatives and their use as sodium channel activators |
| AU2022389558A1 (en) * | 2021-11-19 | 2024-05-23 | Wigen Biomedicine Technology (shanghai) Co., Ltd. | Kif18a inhibitor |
| CN120383543A (zh) * | 2025-06-06 | 2025-07-29 | 康龙化成手性医药技术(宁波)有限公司 | 一种4-氟-2-氮杂双环[2.1.1]己烷盐酸盐的合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US6416780B1 (en) | 1997-05-07 | 2002-07-09 | Galen (Chemicals) Limited | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
-
2022
- 2022-09-23 CN CN202280075808.9A patent/CN120265625A/zh active Pending
- 2022-09-23 EP EP22792990.8A patent/EP4405351A1/en active Pending
- 2022-09-23 MX MX2024003645A patent/MX2024003645A/es unknown
- 2022-09-23 US US17/951,644 patent/US20230203007A1/en not_active Abandoned
- 2022-09-23 JP JP2024518371A patent/JP2024534572A/ja active Pending
- 2022-09-23 CA CA3231743A patent/CA3231743A1/en active Pending
- 2022-09-23 TW TW111136225A patent/TW202328091A/zh unknown
- 2022-09-23 WO PCT/US2022/044562 patent/WO2023049367A1/en not_active Ceased
- 2022-09-23 KR KR1020247013178A patent/KR20240070604A/ko active Pending
- 2022-09-23 AU AU2022351156A patent/AU2022351156A1/en active Pending
- 2022-09-23 IL IL311057A patent/IL311057A/en unknown
-
2024
- 2024-11-05 US US18/937,863 patent/US20250214970A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024534572A5 (https=) | ||
| EP3209656B1 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| KR102093608B1 (ko) | 이미다조피리딘 화합물 | |
| KR102948713B1 (ko) | 설포닐우레아와 관련 화합물 및 그 용도 | |
| JP2021534124A5 (https=) | ||
| TWI911262B (zh) | 化合物、組合物及方法 | |
| AU2015315687B2 (en) | P2X7 modulators | |
| RU2020131091A (ru) | Композиции и способы для лечения расстройств цнс | |
| RU2015106915A (ru) | МОДУЛЯТОРЫ α7 НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА И ИХ ПРИМЕНЕНИЕ | |
| JPH07509728A (ja) | Ｃｒｆアンタゴニストとしてのピラゾロピリミジン | |
| JP2016531134A5 (https=) | ||
| JP2024529527A5 (https=) | ||
| JP2020535165A5 (https=) | ||
| JP2023532298A (ja) | 化合物、組成物及び方法 | |
| WO2010131663A1 (ja) | オキサミド誘導体 | |
| JP2023504542A5 (https=) | ||
| KR102598202B1 (ko) | 3-에틸비사이클로[3.2.0]헵트-3-엔-6-온의 거울상이성질체의 분리 | |
| CN115667236A (zh) | 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物及其应用 | |
| EP3986879A1 (en) | Fused 1,2 thiazoles and 1,2 thiazines which act as nl3p3 modulators | |
| CA3188350A1 (en) | Processes for making serd tricyclic compounds having a substituted phenyl or pyridinyl moiety | |
| TW202342481A (zh) | 腺苷受體拮抗劑化合物 | |
| JP2024522718A (ja) | 神経変性疾患の治療のための、カルボン酸基を含むアゼチジニル化合物 | |
| JP6219955B2 (ja) | ベンゾフラザン抗アミロイド化合物および方法 | |
| JP2016508152A (ja) | Ｃｒａｃチャネル阻害薬としての、ピラゾリルをベースとするカルボキサミド類ｉ | |
| AU2023357827A1 (en) | Cyclopentane compound |